心臓移植治療の市場規模、シェア、動向分析レポート：薬剤タイプ別、流通チャネル別、地域別、セグメント予測、2024年～2030年

市場規模と動向

心臓移植治療の世界市場規模は2023年に10億8,000万米ドルと推定され、2024～2030年にかけてCAGR 4.25％で成長すると予測されています。心不全、冠動脈疾患、心筋症などの心血管疾患（CVDs）の罹患率の上昇が、この成長を大きく後押ししています。例えば、PCRオンラインによると、CVDは世界の男女ともに主要な死因であり続けています。2023年現在、世界人口は80億人であり、約6億2,000万人が心臓・循環器疾患を患っています。毎年、世界中で約6,000万人が心臓・循環器疾患を発症しています。

さらに、肥大型心筋症（HCM）の有病率の増加は、心臓移植治療市場の成長に寄与する主要要因の1つです。肥大型心筋症は、世界で最も一般的な遺伝性心筋症と考えられています。Cleveland Clinicによると、HCMの有病率は世界で約500人に1人と推定されています。この疾患は、不整脈、心不全、心臓突然死などの様々な合併症を引き起こす可能性があります。肥大型心筋症とは別に、他の遺伝性心筋症も市場の成長に効果的な影響を与えます。これらには、拡大型心筋症、拘束型心筋症、不整脈源性右室心筋症が含まれます。拡大型心筋症はHCMよりも有病率が高く、約2,000～2,500人に1人が罹患しています。

臓器提供や移植に関する意識向上への取り組みの高まりにより、死後の臓器提供に同意する人が増えています。例えば、2023年5月、スティーブン・ドネリー保健大臣は、アイルランドにおける臓器提供と移植サービスの進展に焦点を当てた「2023年臓器提供啓発週間」を開始しました。同大臣はスピーチの中で、前年に250件の移植が行われ、2023年の第1四半期には81件の移植が行われるなど、臓器提供システムがCOVID-19の影響から回復し、目覚ましいスタートを切ったことを強調しました。大臣は、移植センター、ICUスタッフ、臓器提供看護師管理者、臓器提供・移植アイルランドなど、このプロセスに関わったすべての人々に感謝の意を表しました。これにより、移植に利用できるドナー心臓の不足が緩和され、心臓移植治療市場の成長を支えています。

さらに、世界の高齢者人口の増加は共通の要因であるが、市場の成長を大きく後押ししています。心臓移植を必要とする可能性のある加齢に関連した心血管疾患の有病率は増加傾向にあります。National Center for Health Statisticsによると、2020年、米国では18歳以上の成人の6.3％が心臓病と診断されました。

2023年、Institute for Health Metrics and Evaluationが1990～2022年までの心血管疾患の世界の負担とリスクについて調査した結果、重要な洞察が明らかになりました。

• 年齢標準化した心血管疾患（CVD）死亡率は地域差があり、2022年には高所得のアジア太平洋の10万人当たり73.6人から東欧の10万人当たり432.3人までの幅があった。
• 世界のCVD死亡率は1990～2022年にかけて34.9％大幅に減少しました。
• 障害調整生存年（DALYs）の主要原因：虚血性心疾患は、年齢標準化DALYsが10万人当たり2,275.9となり、世界の主要原因として浮上しました。脳内出血と虚血性脳卒中が、年齢標準化DALYの顕著なCVD原因として僅差で続いた。
• 年齢標準化CVD有病率：有病率は世界的にばらつきがあり、南アジアの10万人当たり5,881.0人から中央アジアの10万人当たり1万1,342.6人までです。
• 主要な危険因子：高収縮期血圧は、世界全体で10万人当たり2,564.9人で、年齢標準化CVD DALYの最多を占めました。
• 危険因子の重大な変化（1990～2022年）：固形燃料による家庭大気汚染が最も大きな変化を経験し、帰属年齢標準化DALY数が65.1％減少しました。

臓器提供率の向上、移植医療の研究助成、臓器移植に関する規制プロセスの合理化を目的とした政府の取り組みも、心臓移植治療市場の推進に一役買っています。2024年1月、国際心肺移植学会（ISHLT）は、研究活動を支援するために40万米ドル以上の資金を割り当てたことを明らかにしました。これは、進行した心臓と肺の病気を持つ患者のケアを強化することを目的としています。これらの助成金は、ISHLT財団の財政的支援により可能となりました。特筆すべきは、これらの助成金が2023年のISHLT助成金サイクルの第2ラウンドの資金となることです。

心臓移植治療の世界市場セグメンテーションレポート

本レポートでは、世界、地域、国レベルで収益成長を予測し、2018～2030年の各サブセグメントにおける最新の業界動向の分析を提供しています。この調査において、Grand View Research, Inc.は世界の心臓移植治療市場レポートを薬剤タイプ、流通チャネル、地域に基づいてセグメント化しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 心臓移植治療市場の変数、動向、範囲

• 市場系統の展望
  • 親市場展望
  • 関連/付随市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 心臓移植治療市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 心臓移植治療市場：薬剤タイプ、推定・動向分析

• セグメントダッシュボード
• 心臓移植治療市場：薬剤タイプの変動分析
• 心臓移植治療市場の薬剤タイプ別展望
• 2018～2030年の市場規模と予測と動向分析
• 免疫抑制剤
• 抗感染薬
• 鎮痛剤
• その他

第5章 心臓移植治療市場：流通チャネル、推定・動向分析

• セグメントダッシュボード
• 心臓移植治療市場：流通チャネル変動分析
• 心臓移植治療市場の流通チャネル別展望
• 2018～2030年の市場規模と予測と動向分析
• 病院薬局
• 小売薬局
• オンライン薬局

第6章 心臓移植治療市場：地域推定・動向分析

• 地域ダッシュボード
• 地域の心臓移植治療市場変動分析
• 心臓移植治療市場：技術と最終用途別の地域推定・動向分析
• 2018～2030年の市場規模と予測と動向分析
• 北米
  • 北米の心臓移植治療市場推定・予測、2018～2030年
  • 米国
  • カナダ
  • メキシコ
  • 欧州
  • 欧州の心臓移植治療市場推定・予測、2018～2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋の心臓移植治療市場推定・予測、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの心臓移植治療市場推定・予測、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカの心臓移植治療市場推定・予測、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第7章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Astellas Pharma Inc.
  • Biocon Ltd.
  • Dr Reddys Laboratories Ltd.
  • Endo International Plc
  • GlaxoSmithKline Plc
  • Glenmark Pharmaceuticals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Jubilant Pharmova Ltd.
  • LEO Pharma AS
  • Lupin Ltd.

List of Tables

• Table 1. List of Secondary Sources
• Table 2. List of Abbreviations
• Table 3. Global heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 4. Global heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 5. North America heart transplantation therapeutics market, by region, 2018 - 2030 (USD Million)
• Table 6. North America heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 7. North America heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 8. U.S. heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 9. U.S. heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 10. Mexico heart transplantation Therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 11. Mexico heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12. Canada heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 13. Canada heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 14. Europe heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 15. Europe heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 16. Europe Heart Transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 17. UK heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 18. UK heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19. Germany heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 20. Germany heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 21. France heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 22. France heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 23. Italy heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 24. Italy heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25. Spain heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 26. Spain heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 27. Norway heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 28. Norway heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 29. Sweden heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 30. Sweden heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31. Denmark heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 32. Denmark heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 33. Asia Pacific heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 34. Asia Pacific heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 35. Asia Pacific heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 36. Japan heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 37. Japan heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 38. China heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 39. China heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40. India heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 41. India heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 42. Australia heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 43. Australia heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 44. South Korea heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 45. South Korea heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 46. Thailand heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 47. Thailand heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 48. Latin America heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 49. Latin America heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 50. Latin America heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 51. Brazil heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 52. Brazil heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 53. Argentina heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 54. Argentina heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 55. Middle East & Africa heart transplantation therapeutics market, by country, 2018 - 2030 (USD Million)
• Table 56. Middle East & Africa heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 57. Middle East & Africa heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 58. South Africa heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 59. South Africa heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 60. Saudi Arabia heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 61. Saudi Arabia heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 62. UAE heart transplantation Therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 63. UAE heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)
• Table 64. Kuwait heart transplantation therapeutics market, by drug type, 2018 - 2030 (USD Million)
• Table 65. Kuwait heart transplantation therapeutics market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Heart Transplantation Therapeutics market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Heart transplantation therapeutics market, drug type outlook key takeaways (USD Million)
• Fig. 12 Heart transplantation therapeutics market: drug type movement analysis 2023 & 2030 (USD Million)
• Fig. 13 Immunosuppressants market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Anti-infectives market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Analgesics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Heart transplantation therapeutics market, distribution channel outlook key takeaways (USD Million)
• Fig. 18 Heart transplantation therapeutics market: distribution channel movement analysis 2023 & 2030 (USD Million)
• Fig. 19 Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Online pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Heart transplantation therapeutics market: Regional key takeaways (USD Million)
• Fig. 23 Heart transplantation therapeutics market: regional outlook, 2023 & 2030, USD Million
• Fig. 24 North America heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 U.S. heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Canada heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Mexico heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Europe heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 UK heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Germany heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 France heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Spain heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Italy heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Sweden heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Norway heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Denmark heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Asia Pacific heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 China heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Japan heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 India heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 South Korea heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Australia heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Thailand heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Latin America heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Brazil heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Argentina heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Middle East and Africa heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 South Africa heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Saudi Arabia heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 UAE heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Kuwait heart transplantation therapeutics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 List of key emerging company's/technology disruptors/innovators

Market Size & Trends

The global heart transplantation therapeutics market size was estimated at USD 1.08 billion in 2023 and is anticipated to grow at a CAGR of 4.25% from 2024 to 2030. The rising incidence of cardiovascular diseases (CVDs), such as heart failure, coronary artery disease, and cardiomyopathy, majorly drives this growth. For instance, according to the PCR online, CVD continues to be the primary cause of death for both men and women worldwide. As of 2023, the global population is 8 billion, with approximately 620 million individuals living with heart and circulatory diseases. Each year, approximately 60 million people worldwide develop heart or circulatory diseases.

Furthermore, the increasing prevalence of hypertrophic cardiomyopathy (HCM)is one of the major factors contributing to the growth of the market for heart transplantation therapeutics. It is considered the most common inherited cardiomyopathy worldwide. As per the Cleveland Clinic[, the prevalence of HCM is estimated to affect approximately 1 in 500 individuals worldwide. This condition can lead to various complications, including arrhythmias, heart failure, and sudden cardiac death.Apart from hypertrophic cardiomyopathy, other genetic types of cardiomyopathies impact the market growth effectively. These include dilated cardiomyopathy, restrictive cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy. Dilated cardiomyopathy is more prevalent than HCM, affecting about 1 in 2,000 to 2,500 individuals.

The growing efforts to raise awareness about organ donation and transplantation have led to more individuals consenting to donate their organs after death. For instance, in May 2023, the Minister for Health, Stephen Donnelly, launched Organ Donor Awareness Week 2023, focusing on the progress made in organ donation and transplantation services in Ireland. In his speech, he highlighted the system's recovery from the impact of COVID-19, with 250 transplants performed in the previous year and a remarkable start to 2023 with 81 transplants in the first quarter. The Minister expressed gratitude to all involved in the process, including transplant centers, ICU staff, organ donor nurse managers, and Organ Donation and Transplant Ireland. This has helped alleviate the shortage of donor hearts available for transplantation, thereby supporting the growth of the heart transplantation therapeutics market.

Moreover, the rising geriatric population worldwide is a common factor but significantly boosts market growth. The prevalence of age-related cardiovascular conditions that may necessitate heart transplantation is on the rise. Older individuals are more likely to develop heart failure or other cardiac issues that could benefit from heart transplant therapy, thereby driving the market growth.According to the National Center for Health Statistics, in 2020, 6.3% of adults aged 18 years and over had been diagnosed with heart disease in the U.S. This estimate is based on household interviews of a sample of the civilian, noninstitutionalized U.S. population.

In 2023, findings from the Institute for Health Metrics and Evaluation study on the global burden of cardiovascular diseases and risks for 1990-2022 revealed significant insights.

• Age-standardized cardiovascular disease (CVD) mortality rates varied regionally, ranging from 73.6 per 100,000 in High-income Asia Pacific to 432.3 per 100,000 in Eastern Europe in 2022.
• Global CVD mortality significantly decreased by 34.9% from 1990 to 2022.
• Leading Causes of Disability-Adjusted Life Years (DALYs): ischemic heart disease emerged as the leading global cause with age-standardized DALYs at 2,275.9 per 100,000. Intracerebral hemorrhage and ischemic stroke followed closely as prominent CVD causes for age-standardized DALYs.
• Age-standardized CVD Prevalence: Varied globally, with rates ranging from 5,881.0 per 100,000 in South Asia to 11,342.6 per 100,000 in Central Asia.
• Leading Risk Factor: High systolic blood pressure accounted for the largest number of attributable age-standardized CVD DALYs at 2,564.9 per 100,000 globally.
• Significant Changes in Risk Factors (1990 to 2022): Household air pollution from solid fuels experienced the most substantial change, with a 65.1% decrease in attributable age-standardized DALYs.

Government initiatives aimed at improving organ donation rates, funding research in transplant medicine, and streamlining regulatory processes for organ transplantation have also played a role in driving the heart transplantation therapeutics market forward. These supportive measures create a conducive environment for advancements in this field.In January 2024, the International Society for Heart and Lung Transplantation (ISHLT) disclosed that it has allocated over USD 400,000 in funding to support research endeavors. It aims to enhance the care of patients with advanced heart and lung diseases. These grants were made possible through the financial backing of the ISHLT Foundation. Notably, these grants represent the second round of funding for the 2023 ISHLT grant cycles.

Global Heart Transplantation Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global heart transplantation therapeutics market report based on drug type, distribution channel, and region:

• Drug Type Outlook (Revenue, USD Million, 2018 - 2030¬)
• Immunosuppressants
• Anti-infectives
• Analgesics
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Region Outlook (Revenue, USD Million, 2018 - 2030)
• North America

U.S.

Canada

Mexico

• Europe

UK

Germany

France

Italy

Spain

Norway

Sweden

Denmark

• Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

• Latin America

Brazil

Argentina

• Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Drug Type
  • 1.1.2. Distribution Channel
  • 1.1.3. Regional scope
  • 1.1.4. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Drug type outlook
  • 2.2.2. Distribution channel outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Heart Transplantation Therapeutics Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Heart Transplantation Therapeutics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Heart Transplantation Therapeutics Market: Drug Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Heart Transplantation Therapeutics Market: Drug Type Movement Analysis
• 4.3. Heart Transplantation Therapeutics Market by Drug Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Immunosuppressants
  • 4.5.1. Immunosuppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Anti-infectives
  • 4.6.1. Anti-infectives Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Analgesics
  • 4.7.1. Analgesics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Heart Transplantation Therapeutics Market: Distribution Channel Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Heart Transplantation Therapeutics Market: Distribution Channel Movement Analysis
• 5.3. Heart Transplantation Therapeutics Market by Distribution Channel Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Hospital Pharmacies
  • 5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Retail Pharmacies
  • 5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Online pharmacies
  • 5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Heart Transplantation Therapeutics Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Heart Transplantation Therapeutics Market Movement Analysis
• 6.3. Heart Transplantation Therapeutics Market: Regional Estimates & Trend Analysis by Technology & End use
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. North America
  • 6.5.1. North America Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. U.S.
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Reimbursement scenario
    • 6.5.2.5. U.S. Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Reimbursement scenario
    • 6.5.3.5. Canada Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Reimbursement scenario
    • 6.5.4.5. Mexico Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Europe
  • 6.5.6. Europe Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. UK
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Reimbursement scenario
    • 6.5.7.5. UK Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Germany
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Reimbursement scenario
    • 6.5.8.5. Germany Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. France
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Reimbursement scenario
    • 6.5.9.5. France Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.10. Italy
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Reimbursement scenario
    • 6.5.10.5. Italy Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.11. Spain
    • 6.5.11.1. Key Country Dynamics
    • 6.5.11.2. Competitive Scenario
    • 6.5.11.3. Regulatory Framework
    • 6.5.11.4. Reimbursement scenario
    • 6.5.11.5. Spain Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.12. Denmark
    • 6.5.12.1. Key Country Dynamics
    • 6.5.12.2. Competitive Scenario
    • 6.5.12.3. Regulatory Framework
    • 6.5.12.4. Reimbursement scenario
    • 6.5.12.5. Denmark Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.13. Sweden
    • 6.5.13.1. Key Country Dynamics
    • 6.5.13.2. Competitive Scenario
    • 6.5.13.3. Regulatory Framework
    • 6.5.13.4. Reimbursement scenario
    • 6.5.13.5. Sweden Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.14. Norway
    • 6.5.14.1. Key Country Dynamics
    • 6.5.14.2. Competitive Scenario
    • 6.5.14.3. Regulatory Framework
    • 6.5.14.4. Reimbursement scenario
    • 6.5.14.5. Norway Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Reimbursement scenario
    • 6.6.2.5. Japan Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Reimbursement scenario
    • 6.6.3.5. China Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Reimbursement scenario
    • 6.6.4.5. India Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Reimbursement scenario
    • 6.6.5.5. South Korea Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Reimbursement scenario
    • 6.6.6.5. Australia Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Reimbursement scenario
    • 6.6.7.5. Thailand Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Reimbursement scenario
    • 6.7.2.5. Brazil Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Reimbursement scenario
    • 6.7.3.5. Argentina Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Reimbursement scenario
    • 6.8.2.5. South Africa Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Reimbursement scenario
    • 6.8.3.5. Saudi Arabia Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Reimbursement scenario
    • 6.8.4.5. UAE Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Reimbursement scenario
    • 6.8.5.5. Kuwait Heart Transplantation Therapeutics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. Astellas Pharma Inc.
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Biocon Ltd.
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Dr Reddys Laboratories Ltd.
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Endo International Plc
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. GlaxoSmithKline Plc
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Glenmark Pharmaceuticals Ltd.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Intas Pharmaceuticals Ltd.
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. Jubilant Pharmova Ltd.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. LEO Pharma AS
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. Lupin Ltd.
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives